Loading provider…
Loading provider…
Pulmonary Disease Physician in Dallas, TX
NPI: 1245334580Primary Practice Location
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
6201 Harry Hines Blvd, Dallas, TX
Primary Employer
University of Texas Southwestern Medical Center at Dallas
utswmed.org
HQ Phone
Get MD John's Phone Numberphone_androidMobile
Get MD John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1990 - 2026

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of Colorado
Fellowship • Pulmonary Disease and Critical Care Medicine
1992 - 1995
University of Texas Southwestern Medical Center
Residency • Internal Medicine
1989 - 1992
WashU Medicine
medicine.washu.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 248 | 258 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 168 | 173 |
| 3 | 94726Determination of lung volumes using plethysmography | 142 | 145 |
| 4 | 94060Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | 111 | 115 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 103 | 117 |
Sinonasal manifestations of sarcoidosis: a single institution experience with 38 cases.
Authors: Bradley Marple, Matthew Ryan, Sukhpreet Batra, Craig Glazer
Journal: Int Forum Allergy Rhinol
Publication Date: 2013-01-10
Authors: Tristan Huie, Brian Southern, Joao Deandrade, John Belperio, Kristin Highland, Franck Rahaghi, Joseph Lasky, Robert Hallowell, Mridu Gulati
Publication Date: 2021-03-30
Authors: Gary Erwin
Journal: J Asthma
Lead Sponsor: FibroGen
Intervention / Treatment: DRUG: Placebo, DRUG: Sub-Study: Nintedanib, DRUG: Pamrevlumab, DRUG: Sub-Study: Pirfenidone
Lead Sponsor: Duke University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Duke Clinical Research Institute
Intervention / Treatment: DRUG: placebo, DRUG: warfarin
Lead Sponsor: Duke University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: Placebo, DRUG: N-acetylcysteine (NAC)